Biotech ETFs Jump: Keep an Eye on XBI, IBB & SBIO

FAN Editor

This article was originally published on ETFTrends.com.

Biotech ETFs are movin’ on up on news that Pfizer is buying Array BioPharma for over $10 billion. SPDR S&P Biotech (XBI), iShares Nasdaq Biotechnology ETF (IBB), and ALPS Medical Breakthroughs ETF (SBIO) rose with the announcement of the acquisition. ETFs like XBI and IBB have fundamental differences. Depending on an investor’s strategy they can look to […]

Continue Reading Below

Read more at ETFTrends.com >

Free America Network Articles

Leave a Reply

Next Post

Innovator to List MSCI EAFE and Emerging Markets ETFs on NYSE

This article was originally published on ETFTrends.com. A more dovish Federal Reserve and interest rate cuts in 2019 could pave the way for gains in emerging markets. The timing couldn’t be any more auspicious for Innovator Capital Management, LLC (Innovator), who announced plans to expand the category creating Innovator Defined […]